drugset / Trial / NCT02323373

Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty

NCT02323373

RandomizedParallel-groupSingle-blindPrevention

Summary

This clinical trial investigated two different routes of administration of tranexamic acid in total knee arthroplasty: topical compared to intravenous.

Timeline

Start
2014-06
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 20 mg/kg Topical
Subject Tranexamic Acid Small molecule 1.5 g Topical

Indications